Search results
FDA advisers endorse Eli Lilly’s early-stage Alzheimer’s drug donanemab
CNN via Yahoo News· 3 days agoOn Monday, a panel of independent advisers to the US Food and Drug Administration voted to endorse Eli Lilly’s drug donanemab, a monoclonal antibody designed ...
Acticor Biotech Fab Fragment Development & Manufacturing
BioresearchOnline· 24 hours agoGlenzocimab (ACT017) is a humanized Fab fragment of a monoclonal antibody, targeting platelet...
AbbVie inks deal potentially worth $1.7 billion for new IBD drug
Crain s Chicago Business· 4 hours agoAbbVie's latest move in inflammatory bowel disease treatments is a licensing agreement to develop a next generation antibody engineered by Beijing-based FutureGen. The terms of the deal call ...
Qilu Pharmaceutical's Three Clinical Studies on Cancer Immunotherapy Presented at ASCO 2024
FOX 16 Little Rock· 7 days agoThe 2024 American Society of Clinical Oncology (ASCO) Annual Meeting convened from May 31 to June 4, 2024 in Chicago, USA, adopting a hybrid format. Among the presented works, three clinical ...
Opinion: San Diego's life sciences industry has long history of historic breakthroughs
U-T San Diego· 2 days agoPanetta is president and chief executive officer at Biocom California and lives in San Diego. Guerra...
'Something I never saw coming': Canadian powerlifter spent 5 weeks on life support after developing...
Yahoo Canada Style· 1 day agoThis article is for informational purposes only and is not a substitute for professional medical...
Dianthus receives FDA greenlight to begin Phase II trial in MMN
Clinical Trials Arena via Yahoo Finance· 1 day agoInitial top-line results are slated for the second half of 2026, according to the US biotech....
A Guide to Managing COVID This Summer
The New York Times via Yahoo News· 1 day agoAs new variants of the coronavirus continue to gain traction, doctors and researchers are bracing for a potential rise in cases this summer. Two of these...
Anti-CD20 HGG Linked to Serious Infection Risk in MS
Medscape· 7 days agoHypogammaglobulinemia is a known risk linked to B-cell–depleting therapies, but a real-world study has specified the risk and risk factors in multiple...
Amid big Bayer shakeup, drugmaker loses Berkeley-based biotech chief - San Francisco Business Times
The Business Journals· 2 days agoJens Vogel, who as global head of biotech led Bayer AG's push into cell therapy manufacturing from...